Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.0 - $0.47 $0 - $386
822 New
822 $0
Q2 2022

Aug 15, 2022

SELL
$0.56 - $1.31 $2,194 - $5,132
-3,918 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$0.43 - $1.7 $577 - $2,281
-1,342 Reduced 25.51%
3,918 $3,000
Q4 2021

Feb 14, 2022

BUY
$1.26 - $2.45 $2,727 - $5,304
2,165 Added 69.95%
5,260 $8,000
Q3 2021

Nov 15, 2021

SELL
$2.26 - $4.29 $784 - $1,488
-347 Reduced 10.08%
3,095 $8,000
Q2 2021

Aug 16, 2021

BUY
$2.65 - $5.72 $5,930 - $12,801
2,238 Added 185.88%
3,442 $14,000
Q1 2021

May 17, 2021

BUY
$5.21 - $8.25 $6,272 - $9,933
1,204 New
1,204 $7,000

Others Institutions Holding GBS

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About GBS Inc.


  • Ticker GBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,889,900
  • Description
  • GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...
More about GBS
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.